Biotage Stock

Biotage Net Margin

Delisted

The Net Profit Margin of Biotage (BIOT.ST) as of Jul 30, 2026 is 13.81 %. In the previous year, Net Profit Margin was 13.21 % — a change of 4.55% (higher).

Net Margin

13.81 %

YoY

4.55%

Last updated:

Net Profit Margin of Biotage is 2026 13.81 % . Net Profit Margin of Biotage was 2025 13.21 % . It decreases by 4.55% higher compared to the previous year.

Biotage's net margin stands at 13.8%, down from 16.0% several years earlier.

Access this data via the Eulerpool API

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotage stock

Net Profit Margin of Biotage is 13.81 % in 2026.

Access this data via the Eulerpool API

Margins — Biotage

All Key Metrics — Biotage